BIG Breast International Group
We will find a cure for breast cancer through global research and collaboration.

BIG 1-07 SOLE

The Study Of Letrozole Extension (SOLE) study is a phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, node-positive early stage breast cancer.

Coordinating group: IBCSG

Patients accrual
Start date: November 2007
Closure date: October 2012
Target nr. of patients: 4800
Final accrual: 4884

Reason for closure: reached targed accrual
ClinicalTrials.gov Identifier: NCT00553410

To learn more, visit: http://www.ibcsg.org/Public/Health_Professionals/Closed_Trials/IBCSG_35-07/Pages/IBCSG35-07%28SOLE%29.aspx

Scroll to top

Contact us

Breast International Group (BIG)-aisbl Blvd de Waterloo 121 B-1000 Brussels | Belgium VAT BE 0468 176 240